(R) -Zadavotide guraxetan
Zadavotide guraxetan (PSMA I&T; PNT-2002) is a prostate-specific membrane antigen (PSMA) inhibitor. Zadavotide guraxetan has antitumor activity and can be used in prostate cancer-targeted research[1][2].
Product Specifications
CAS Number
2647371-60-4
Product Name Alternative
(R) -PSMA I&T; (R) -PNT-2002
UNSPSC
12352209
Target
PSMA
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(CC[C@@H](N1CCN(CCN(CCN(CC1)CC(O)=O)CC(O)=O)CC(O)=O)C(O)=O)N[C@H](CC2=CC(I)=C(O)C=C2)C(N[C@H](CC3=CC=CC=C3)C(N[C@H](CCCCNC(CCCCCCC(NCCCC[C@H](NC(N[C@@H](CCC(O)=O)C(O)=O)=O)C(O)=O)=O)=O)C(O)=O)=O)=O
Molecular Formula
C63H92IN11O23
Molecular Weight
1498.37
References & Citations
[1]WHO. International Nonproprietary Names for Pharmaceutical Substances (INN), Proposed International Nonproprietary Names: List 132. WHO Drug Information, Vol. 38 , No. 4, 2024.|[2]Weineisen M, et al. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies. J Nucl Med. 2015 Aug;56 (8) :1169-76.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
